TY - JOUR
T1 - Pulmonary tuberculosis induces a systemic hypercoagulable state
AU - Kager, Liesbeth M.
AU - Blok, Dana C.
AU - Lede, Ivar O.
AU - Rahman, Wahid
AU - Afroz, Rumana
AU - Bresser, Paul
AU - van der Zee, Jaring S.
AU - Ghose, Aniruddha
AU - Visser, Caroline E.
AU - de Jong, Menno D.
AU - Tanck, Michael W.
AU - Zahed, Abu Shahed M.
AU - Alam, Khan Mashrequl
AU - Hassan, Mahtabuddin
AU - Hossain, Ahmed
AU - Lutter, Rene
AU - Veer, Cornelis Van't
AU - Dondorp, Arjen M.
AU - Meijers, Joost C. M.
AU - van der Poll, Tom
PY - 2015
Y1 - 2015
N2 - Human tuberculosis (TB) remains an important cause of death globally. Bangladesh is one of the most affected countries. We aimed to investigate the impact of pulmonary TB on pro- and anticoagulant mechanisms. This prospective study was conducted in Chittagong, Bangladesh. We performed an in-depth analysis of coagulation activation and inhibition in plasma obtained from 64 patients with primary lung TB and 11 patients with recurrent lung TB and compared these with 37 healthy controls. Additionally, in nine patients coagulation activation was studied in bronchoalveolar lavage fluid (BALF) harvested from the site of infection and compared with BALF from a contralateral unaffected lung subsegment. Relative to uninfected controls, primary and recurrent TB were associated with a systemic net procoagulant state, as indicated by enhanced activation of coagulation (elevated plasma levels of thrombin-antithrombin complexes, D-dimer and fibrinogen) together with impaired anticoagulant mechanisms (reduced plasma levels of antithrombin, protein C activity, free protein S, and protein C inhibitor). Activation of coagulation did not correlate with plasma concentrations of established TB biomarkers. Coagulation activation could not be detected at the primary site of infection in a subset of TB patients. Pulmonary TB is associated with a systemic hypercoagulable state
AB - Human tuberculosis (TB) remains an important cause of death globally. Bangladesh is one of the most affected countries. We aimed to investigate the impact of pulmonary TB on pro- and anticoagulant mechanisms. This prospective study was conducted in Chittagong, Bangladesh. We performed an in-depth analysis of coagulation activation and inhibition in plasma obtained from 64 patients with primary lung TB and 11 patients with recurrent lung TB and compared these with 37 healthy controls. Additionally, in nine patients coagulation activation was studied in bronchoalveolar lavage fluid (BALF) harvested from the site of infection and compared with BALF from a contralateral unaffected lung subsegment. Relative to uninfected controls, primary and recurrent TB were associated with a systemic net procoagulant state, as indicated by enhanced activation of coagulation (elevated plasma levels of thrombin-antithrombin complexes, D-dimer and fibrinogen) together with impaired anticoagulant mechanisms (reduced plasma levels of antithrombin, protein C activity, free protein S, and protein C inhibitor). Activation of coagulation did not correlate with plasma concentrations of established TB biomarkers. Coagulation activation could not be detected at the primary site of infection in a subset of TB patients. Pulmonary TB is associated with a systemic hypercoagulable state
U2 - https://doi.org/10.1016/j.jinf.2014.10.006
DO - https://doi.org/10.1016/j.jinf.2014.10.006
M3 - Article
C2 - 25455017
SN - 0163-4453
VL - 70
SP - 324
EP - 334
JO - Journal of Infection
JF - Journal of Infection
IS - 4
ER -